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Vector-borne pathogens are inoculated in the skin of mammals, most likely in the dermis. Despite this, subcutaneous (s.c.)
models of infection are broadly used in many fields, including Yersinia pestis pathogenesis. We expand on a previous report
where we implemented intradermal (i.d.) inoculations to study bacterial dissemination during bubonic plague and compare this
model with an s.c. model. We found that i.d. inoculations result in faster kinetics of infection and that bacterial dose influenced
mouse survival after i.d. but not s.c. inoculation. Moreover, a deletion mutant of rovA, previously shown to be moderately atten-
uated in the s.c. model, was severely attenuated in the i.d. model. Lastly, based on previous observations where a population bot-
tleneck from the skin to lymph nodes was observed after i.d., but not after s.c., inoculations, we used the latter model as a strat-
egy to identify an additional bottleneck in bacterial dissemination from lymph nodes to the bloodstream. Our data indicate that
the more biologically relevant i.d. model of bubonic plague differs significantly from the s.c. model in multiple aspects of infec-
tion. These findings reveal adaptations of Y. pestis to the dermis and how these adaptations can define the progression of disease.
They also emphasize the importance of using a relevant route of infection when addressing host-pathogen interactions.
Host-pathogen interactions begin with transmission and con-tinue as the pathogen disseminates into deeper tissues. These
tissues are in themselves microenvironments with defined immu-
nological characteristics and can serve as barriers to prevent
spread. For arthropod-borne pathogens, the skin epithelium is the
first barrier that must be surpassed to penetrate into deeper organs
(1, 2). The complexity of the immune responses of each layer of
the skin reflects the specificity at which this tissue can act upon
invaders.
Based on its histological architecture, the skin can be di-
vided into three main layers, namely, epidermis, dermis, and
subcutaneous space (also known as hypodermis) (3). Each
layer encompasses not only specific architectural qualities but
also unique immunological characteristics that define them
(2). How these characteristics influence the progression of in-
fection is unknown. The epidermis is the outermost layer of the
skin and constitutes a strong physical barrier that pathogens
must cross to enter the body. Pathogens that survive in blood-
feeding arthropods can cross this layer through the mechanical
action of the arthropod’s probing mouth parts (4). Conse-
quently, the dermis, located immediately adjacent to the epi-
dermis, is highly exposed to these pathogens. Because most
arthropod vectors do not penetrate beyond the dermis to the
subcutaneous (s.c.) space, the dermis is, most likely, the first
tissue where initial host-pathogen interactions occur during
vector-borne infections (1, 5–7).
Yersinia pestis is a Gram-negative bacterium and the causative
agent of plague. This highly virulent pathogen was responsible for
major pandemics in history and continues to survive in animal
reservoirs in many parts of the world (8, 9). Bubonic plague is the
most prevalent form of the disease and occurs after bacterial in-
oculation into the skin, typically by a flea vector (10). From the
skin, Y. pestis disseminates to draining lymph nodes (LNs) via
lymphatic vessels (11) and then to deeper organs through the
bloodstream (12). Systemic dissemination results in septic shock,
severe organ failure, and death.
Models of infection that target the s.c. space are broadly used in
plague research (13–16) as this is a relatively easy tissue to target.
However, the dermis is strongly implicated as the layer of the skin
probed by fleas during transmission (5, 17). In comparison with
s.c. models, intradermal (i.d.) inoculations require more dexterity
and can be more challenging to implement in biosafety level three
facilities, which are mandatory when handling fully virulent
strains of Y. pestis. In this study, we further characterize the i.d.
model we used in a previous study (11) and compare i.d. and s.c.
inoculations to investigate whether infection model impacts pro-
gression of bubonic plague. We found substantial differences in
disease progression after inoculation by the two different routes.
In addition, we found that dissemination of bacteria from the LNs
is restricted. These findings are relevant for the understanding of
Y. pestis dissemination and pathogenesis and of host responses to
different inoculation routes. Moreover, our study emphasizes the
importance of using a biologically relevant model when studying
host-pathogen interactions in vivo.
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MATERIALS AND METHODS
Bacterial cultures. Fully virulent Y. pestis CO92 was used in all the exper-
iments of this study (18, 19). Bacteria were streaked on brain heart infu-
sion (BHI; BD Biosciences, Bedford MA) agar plates from frozen stocks
and incubated at 26°C for 48 h. Liquid cultures in BHI broth were incu-
bated for 15 h at 26°C with aeration. The rovA strain was constructed by
allelic exchange, as described elsewhere (20). The psaA strain was con-
structed using the  Red recombination system, as described elsewhere
(20, 21). The procedures employed to construct the isogenic set of 10
tagged strains used in the dissemination assays were previously described
(11, 22). These 10 Y. pestis tagged strains have growth and virulence char-
acteristics similar to those of untagged bacteria (11). For the dose-depen-
dent survival assays (DDSA), an untagged wild-type (WT) strain was
used.
Animal inoculations. Female C57BL/6J mice (6 to 8 weeks old; Jack-
son Laboratory, Bar Harbor, ME) were inoculated with Y. pestis after
injection of a ketamine-xylazine mix. Intradermal (i.d.) inoculations were
performed as previously described (11). Briefly, 200 CFU in 2 l was
injected into the dorsal leaflet of the ear pinna with the aid of a Pump11
Elite syringe pump (Harvard Apparatus, Holliston, MA). The same pro-
cedure was used for the subcutaneous (s.c.) inoculations except that mice
were injected in the ventral cervical region. Organs were harvested at
different time points, homogenized, diluted, and plated on BHI agar to
enumerate the bacteria in each organ. For the i.d. and s.c. inoculations, the
superficial parotid LNs and the superficial cervical LNs, respectively, were
harvested (23).
For the assay to determine the presence of a bottleneck, 9 of the 10
tagged strains were grown in BHI broth with 25 g/ml kanamycin. The
cultures were then mixed (equal optical density at 600 nm [OD600] for
each culture) and used to inoculate mice as previously described (11). For
both routes (i.d. and s.c.), 200 CFU of the mix was inoculated (22 CFU
of each of the nine tagged strains). The 10th tagged strain was omitted
from the mix so it could be used as a negative control. Bacteria recovered
from tissues were used for DNA extraction, this DNA was then used as a
probe for Southern dot blot analysis, and results from the blots were
scored as previously described (11). Statistical analysis was performed
using a Mann-Whitney or Wilcoxon matched-pairs signed-rank test cal-
culated by GraphPad Prism version 4.0c for Macintosh (GraphPad Soft-
ware, La Jolla, CA). We established statistical significance at a P of 0.05.
This study was carried out in accordance with the Guide for the Care
and Use of Laboratory Animals of the National Institutes of Health (24). All
animal studies were approved by the Institutional Animal Care and Use
Committee of the University of North Carolina at Chapel Hill (protocol
11-128). All efforts were made to minimize suffering; animals were mon-
itored every 12 h following inoculation and were euthanized upon exhib-
iting signs of morbidity.
RESULTS
Y. pestis does not proliferate in the skin. We previously used a
murine i.d. model of infection in which the inoculum (200
CFU) was injected in the dermis of the ear pinna (11). Because of
the absence of subcutaneous tissue in the ear, this model results in
i.d., as opposed to s.c., inoculation (25). A key attribute of our
model is the use of a 2-l inoculation volume, which contrasts
with the 10-l volume reported in previous studies using i.d. in-
oculation in the ear (25, 26). We considered that in comparison
with larger volumes, the 2-l model would mimic more closely
the small volume that must be deposited by a flea during natural
inoculations. In addition, the size of the injection wheal produced
by a 10-l volume in the skin is much larger than that produced by
a 2-l volume (Fig. 1A); we postulated that larger volumes could
generate confounding effects due to tissue disruption. Thus, we
established 2 l as a preferred volume of inoculation. With this
model, we noted that bacterial loads in the skin do not change
significantly over time except when mice are subjected to neutro-
phil depletion (11). Because it has been reported that bacterial
loads increase in the skin during Y. pestis infections (25, 26), we
revisited our model to consider possible explanations for this dis-
crepancy. Thus, we asked whether the inoculation volume affects
bacterial proliferation in the skin. We compared bacterial loads in
the skin after injection of the same bacterial dose using either 2 or
10 l as the inoculation volume at a time point that precedes
systemic dissemination (24 h postinoculation [hpi]). We found a
small but significant increase in the number of CFU in the skin of
mice injected with 10 l in comparison with that in mice injected
with 2 l (Fig. 1B). This indicates that larger volumes of inocula-
tion favor bacterial proliferation in the skin.
We also considered the possibility that the reported increase in
bacterial numbers in the skin derives from measurements taken
when the bacteria are circulating systemically (time points after 24
hpi). To test this, we inoculated mice in the right ear, and at 48 hpi,
we determined the bacterial burdens in the left and right ears. The
number of bacteria in the inoculated ear (right ear) was signifi-
cantly larger than the 200 CFU that was inoculated, which could
FIG 1 Bacterial proliferation in the dermis. (A) Mouse ear after injection of a
volume of 2 l (small circle) and 10 l (large circle). The white dotted lines
delineate the edges of the injection wheal (bubble). (B) Numbers of CFU in
ears harvested at 24 hpi using a volume of 2 or 10 l. The horizontal lines
depict the median value of a group. All values were over the limit of detection.
Spleens of these animals were negative (i.e., systemic spread had not occurred).
Differences between groups were determined by a Mann-Whitney test, and the
obtained P value is shown. (C) Numbers of CFU in right and left ears harvested
at 48 hpi. Only the right ear was inoculated. Ears (left and right) represented
with the same symbol (circle, triangle, or square) and color (black, gray, or
white) belong to the same mouse, so a direct comparison between the inocu-
lated and noninoculated ears can be appreciated. The horizontal lines depict
the median value of a group. All values are over the limit of detection (dotted
line). Differences between groups were determined by a Wilcoxon matched-
pairs signed-rank test. For panels B and C, significance was established at a P of
0.05. Each symbol represents the number of CFU obtained from a tissue, and
the dotted line shows the limit of detection. Data from two combined inde-
pendent experiments are shown.
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be interpreted as Y. pestis proliferating in the skin. However, the
bacterial loads in this ear were comparable to those in the unin-
oculated ear (left ear) (Fig. 1C). This suggests that large numbers
of bacteria in the skin at later stages of infection derive from
bacteria circulating systemically and not necessarily from net
bacterial proliferation in this tissue. Of note, it is possible that
inoculations with very high doses (2,000 CFU) affect neutro-
phil activity (11) and result in bacterial proliferation. However,
we think that these events are not relevant, as flea inoculations
rarely result in high bacterial doses in the skin. Thus, overall,
our data suggest that Y. pestis does not proliferate significantly in
the dermis of the skin.
Intradermal inoculations result in faster kinetics but lower
mortality rates than s.c. inoculations. We recently reported the
presence of a bottleneck during i.d. inoculations and that the bot-
tleneck was not observed when the bacteria were injected s.c. (11).
With this important difference between the i.d. and s.c. models,
we hypothesized that inoculations into these different layers of the
skin could affect disease progression. To test this, mice were inoc-
ulated i.d. (ear, harvesting the parotid LN) or s.c. (scruff of the
neck, harvesting the cervical LN), and bacterial loads in draining
LNs and spleens at 48 hpi were determined (Fig. 2A). The median
number of bacteria in LNs of mice inoculated i.d. was 100-fold
higher than the median value in LNs of mice inoculated s.c. This
difference was determined to be statistically significant (Mann-
Whitney test, P  0.0002). Bacterial burdens in the spleen, an
organ used to assess systemic dissemination, showed an even
larger difference between groups. The median number of bacteria
in spleens from mice inoculated i.d. was 106-fold higher than in
mice inoculated s.c. Faster kinetics of dissemination after i.d. in-
jections do not derive from the anatomical localization of the
draining LN, as the site of inoculation in the ear is considerably
more distant to its draining LN than the site of inoculation in the
neck, which is adjacent to the cervical draining LNs. These data
indicate that the route of inoculation affects the kinetics of infec-
tion.
We had noted that when mice were inoculated i.d. with our
normal dose (200 CFU), approximately 1/10 of the animals did
not have bacteria in the LNs (data not shown). These mice had
the expected numbers of bacteria in the ear, confirming that they
were inoculated properly. This suggests that the inoculation route
could also impact mouse survival. A dose-dependent survival as-
say (DDSA) was used to determine differences in survival times
for each of the inoculation routes. A DDSA can also reveal how
these differences are influenced by the dose (number of CFU in the
inocula). Mice were inoculated i.d. with a low (7-CFU), me-
dium (71-CFU), or high (710-CFU) dose, and survival was
monitored during the following 14 days. Inoculation with the low
dose resulted in 67% mouse survival (Fig. 2B). Survival rates of
mice inoculated with the medium and high doses were 25% and
0%, respectively. For the whole group, death was first observed at
day 2. Most mice died between days 2 and 4, with the exception of
one mouse from the low-dose group, which died on day 11. For
the group inoculated s.c., the doses used were 24 CFU, 240
CFU, and 2,400 CFU. Regardless of the dose, no mice inoculated
FIG 2 Kinetics of infection and survival in mice inoculated i.d. and s.c. (A)
Numbers of CFU from LNs (circles) and spleens (squares) harvested 48 h after
i.d. (black symbols) or s.c. (white symbols) inoculation. Each symbol repre-
sents the number of CFU obtained from a tissue. The horizontal lines depict
the median value of a group. Differences between groups were determined by
a Mann-Whitney test. Significance was established at a P of 0.05. The dotted
line shows the limit of detection. Data from two combined independent ex-
periments are shown. (B and C) DDSA of mice inoculated i.d. (B) or s.c. (C)
using three different doses. Each line depicts the percentage of mice surviving
in a group (n  8 per inoculum for i.d., n  6 per inoculum for s.c.) at different
time points (in days). The dose for each group is shown in the upper right
corner of each panel. Data from one representative experiment are shown.
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s.c. survived (Fig. 2C). With the exception of one mouse in the
high-inoculum group that died at day 3.5, all mice died between
days 4.5 and 7. These data indicate that mouse survival after i.d.
inoculation, but not after s.c. inoculation, appeared to be linked to
inoculum size.
A deletion mutant lacking a global regulator of Y. pestis is
more attenuated after i.d. inoculation than after s.c. inocula-
tion. We previously demonstrated that after s.c. inoculation, Y.
pestis deletion mutants lacking the transcriptional regulator RovA
or the putative antiphagocytic factor PsaA are attenuated (20, 27).
Microarray and reverse transcription-quantitative PCR (qRT-
PCR) analyses revealed that expression of psaA was substantially
decreased in the rovA strain. Because the degrees of attenuation
of the two mutants were similar, we inferred that PsaA was the
main (if not the only) virulence factor regulated by RovA during
bubonic plague. Since we found important differences between
our i.d. and s.c. models, we asked whether mutants characterized
in the s.c. model would behave in the same way after i.d. inocula-
tion. Thus, we tested the rovA and psaA strains in our i.d.
model. We used time points relevant to the kinetics for this route
(24 and 48 hpi), and in addition to LNs and spleens, we also har-
vested ears (site of inoculation). Both rovA and psaA strains
were attenuated compared to WT Y. pestis (Fig. 3A, B, and C). At
24 hpi, the two mutant strains showed similar levels of attenuation
in the ears and LNs when compared to one another. However, in
contrast to what was observed in the s.c. model, the rovA strain
was significantly more attenuated than the psaA strain at 48 hpi
(Fig. 3). This difference was especially evident in LNs at 48 hpi
(Fig. 3 B), where the median value of bacterial counts of the rovA
strain was at the limit of detection and the median number of CFU
for the psaA strain was 6 logs higher. Significant differences be-
tween the two strains were also observed in ears and spleens, al-
though this most likely reflects delays in systemic infection by the
rovA strain that resulted from the lower levels of LN colonization
by this mutant (Fig. 3A and C). Overall, this indicates that after i.d.
inoculation, Y. pestis lacking rovA is significantly more attenuated
than Y. pestis lacking psaA. This finding differs from what was
observed after s.c. inoculations, in which case both mutants were
equally attenuated (20).
An s.c. route of inoculation reveals a bottleneck in bacterial
dissemination from LNs to deeper organs. Using oligonucleo-
tide-tagged isogenic strains of Y. pestis, we previously identified a
bottleneck during early stages of infection following i.d. inocula-
tion (11); only a small fraction of the tagged strains that were
FIG 3 Kinetics of infection of rovA and psaA mutants after i.d. inoculation. Bacterial loads were determined in ears (A), LNs (B), and spleens (C) harvested
at the indicated times after i.d. inoculation with 200 CFU of WT (black), rovA mutant (gray), or psaA mutant (white) Y. pestis. Each symbol represents the
number of CFU obtained from a tissue. The horizontal lines depict the median of the group. Differences between groups were determined by a Mann-Whitney
test, and the obtained P value is shown. Data shown are from one experiment for the 24 hpi time point and from three combined independent experiments for
the 48 hpi time point. Significance was established at a P of 0.05. The dotted line shows the limit of detection.
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inoculated i.d. into the skin were subsequently present in draining
LNs. This suggested that the bottleneck affected bacterial dissem-
ination from the skin to the LNs. We suspected that a second
bottleneck existed in the dissemination of Y. pestis from the LNs to
systemic sites, because in some instances a tagged strain that was
present in the LNs was absent in the spleen. However, this was
difficult to test because the number of tagged strains in the LNs
after i.d. inoculations is very low. Thus, it is impossible to assess
any further reduction in the numbers of tagged strains beyond the
LNs. Notably, in the same study, we found that the bottleneck was
almost completely abrogated when Y. pestis was inoculated s.c., as
nearly all tagged strains were found in draining LNs (Fig. 4A).
Therefore, we used this model as a strategy to test whether Y. pestis
passes through a bottleneck when disseminating from LNs to sys-
temic circulation. We assumed that the route of inoculation af-
fects only dissemination from the skin to the LNs and does not
affect dissemination beyond this compartment. Mice were inocu-
lated s.c. with nine tagged strains, and LNs and spleens were har-
vested at 72 hpi, a time point when the numbers of CFU in the
spleens are close to maximal. Five out of six mice had fewer tagged
FIG 4 Bottleneck from LNs to spleen revealed after s.c. inoculation. (A) Southern dot blot of bacterial DNA obtained from the LNs of mice inoculated s.c. with
nine oligonucleotide-tagged strains of Y. pestis. LNs were harvested at 48 hpi. Each row depicts the results for a single mouse. Each strain is identified (A1 to A5
and B1 to B4; A6 was used as a negative control). (B) Comparison of tagged strains present in LNs and spleens at 72 h after s.c. inoculations. Each row depicts the
results from a single mouse (six mice used). The number of CFU obtained from a tissue and from which DNA was extracted is also shown. Plates that were
completely covered with a layer of bacteria (as opposed to isolated colonies) are identified as “lawn.” Plates with isolated colonies that were too numerous to count
are identified as “TNTC.” Tagged strains in each organ are shown as present (gray) or absent (white). The “X” symbol represents tagged strains present in LNs
that are absent in spleens. For panels A and B, results from one representative experiment are shown. (C) Quantification of tagged strains present in LNs and
spleens at 48 h after s.c. inoculation. Each symbol represents the number of tags obtained from a tissue. Horizontal lines represent the median of the group.
Statistically significant differences between groups were determined by a Mann-Whitney test establishing significance at a P of 0.05.
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strains in the spleens than in the LNs (Fig. 4B). The number of
tagged strains present in the LNs but absent in the spleens ranged
from five to eight. Differences between the numbers of tagged
strains in LNs and spleens were significant (Fig. 4C). These data
indicate that only a few of the tagged strains in the LNs predomi-
nate in a systemic organ (spleen).
DISCUSSION
Only in recent years have we begun to appreciate the significance
of the differences between in vivo and in vitro approaches to study-
ing host-pathogen interactions. This has resulted in the develop-
ment of new animal models with a goal of mimicking natural
infections as closely as possible. However, a major limitation of
implementing animal models is how little is known about what
aspects of a natural infection truly affect disease progression. In
this study, we report important differences in the progression of
bubonic plague in a comparison of the more commonly used s.c.
route and the more biologically relevant i.d. route.
We observed that bacteria are able to colonize the host more
rapidly (i.e., faster kinetics) after i.d. than after s.c. inoculations.
This might be due to differences in the density and the anatomy of
lymphatic vessels in each layer of the skin. The dermis is rich in
terminal lymphatic vessels, which are absent in the epidermis and
the s.c. space (28). Terminal lymphatic vessels lack smooth muscle
cells and a basal membrane. The absence of these two elements
increases the permeability of the vessels and makes them able to
readily take up lymph and antigen (29). This is exemplified by
experiments in which dyes to map lymphatic vessels for tumor
detection are detected faster in LNs after i.d. injection than in LNs
after s.c. injection (30). Unlike terminal lymphatic vessels, collect-
ing lymphatics possess circumferential smooth muscle cells, are
surrounded by a basement membrane, and are found in the s.c.
layer of the skin (29). The presence of smooth muscle cells and a
basement membrane restricts the access of particles into the lu-
men of the lymphatic vessels and makes them less efficient in
antigen uptake. In addition to lymphatic vessel physiology, it also
has been suggested that the dermis is subject to high fluid pres-
sures (28). High pressures are important to drain fluid from the
dermis to prevent edema and could also contribute to more effi-
cient movement of Y. pestis to the LNs. This is especially true if, as
we have previously suggested, Y. pestis travels to LNs freely with
the flow of lymph (11). Thus, this suggests that Y. pestis cannot
access LNs through lymphatic vessels as easily when deposited in
the s.c. space as when deposited into the dermis.
Intriguingly, we found that while the kinetics of infection are
faster when Y. pestis is delivered into the dermis, some mice sur-
vive after i.d. inoculation but none after s.c. inoculation. This is
most evident when low inocula are used. Most mice survived after
inoculation of 7 CFU in the dermis and none after inoculation of
a very similar dose (24 CFU) in the s.c. space. In our bottleneck
study, we found that a small percentage of i.d. inoculated mice did
not have any detectable bacteria in their LNs and spleens (11).
This suggested that the bottleneck could be highly efficient. It
would be expected that the effects of a barrier (i.e., bottleneck)
that limits dissemination to LNs are stronger when few bacteria
are inoculated and weaker when larger numbers of bacteria are
used. Consequently, all mice inoculated i.d. with a high inoculum
(710 CFU) died, and most of the mice inoculated with a low
inoculum (7 CFU) survived. Unlike the dermis, the s.c. layer of
the skin possesses a very limited number of resident cells of the
immune response (31). In addition, the s.c. space is less vascular-
ized than the dermis, and, thus, access to it by infiltrating immune
cells might be less efficient (3, 31). We speculate that a less efficient
immune response could allow for local bacterial replication in the
s.c. space favoring subsequent dissemination that is not influ-
enced by an initial low dose.
The use of the i.d. model also demonstrated a more pro-
nounced attenuation of the rovA mutant than previously ob-
served using the s.c. model (20). We speculate that this indicates a
role for RovA-regulated genes in bacterial adaptation to the im-
mune response of the dermis. While many aspects of the anatomy
and physiology of the different layers of the skin are understood,
their effects on the immune response to pathogens are not clear.
However, studies in the cancer and vaccine development fields
have shed some light on the effects of the immune responses of the
different layers of the skin. Bonnotte and collaborators found that
injection of a tumorigenic cell line results in tumor formation
after s.c. but not i.d. injection in rats (32). In another study, injec-
tion of a virus-like particle to test its immunogenicity showed
more LN involvement and cellular response after i.d. injection
than with s.c. delivery (33). In addition, results favoring the use of
i.d. over s.c. inoculations have been reported in experiments using
an HIV-1 antigen in vaccine development against this virus (34).
Much less work has been done comparing routes of inoculation
during cutaneous infections caused by vector-borne pathogens.
One exception is the work done with Leishmania parasites in
which the use of an i.d. route appeared to recreate disease progres-
sion more accurately than an s.c. route (7). Together these studies
indicate that the different layers of the skin differ considerably in
the immune responses they can elicit. Differences in the immune
response might account for the different phenotypes that the
rovA strain shows after inoculation in each layer of the skin.
Thus, in the s.c. space, RovA seems to be primarily important as a
regulator of a single locus (psa). In contrast, in the dermis, the
more severe attenuation of the rovA strain suggests that RovA
regulates additional genes that play a relevant role during infec-
tion. Our experiments highlight the importance of using a biolog-
ically relevant model when determining the levels of attenuation
of deletion mutants.
Lastly, while we support the use of an i.d. model of infection,
we think s.c. inoculations can be useful as an experimental strategy
to answer some questions regarding bacterium-host interactions.
For example, we used the s.c. model as an experimental strategy to
test for the reduction of tagged strains during late stages of infec-
tion (dissemination from LNs to systemic sites). This reduction
had already been observed in the i.d. route, but quantification was
challenging. The s.c. inoculation route resulted in enough tagged
strains in the LNs to determine whether any of them were lost as
disease progressed to a systemic organ. With this strategy, we con-
firmed that only a fraction of the tagged strains present in the LNs
predominate in the spleen. This is in agreement with our defini-
tion of a bottleneck. While the exact location of this bottleneck is
unknown, we think it might result from as yet uncovered immune
processes in the LNs or blood.
For vector-borne infections, including bubonic plague, well-es-
tablished models might need to be revisited and modifications to
these models might need to be considered to optimize our ability to
make biologically relevant observations. As we established, in addi-
tion to being more biologically relevant, the observations made using
these approaches differ considerably from those obtained by more
Gonzalez et al.
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conventional alternatives. Overall, we propose that approaches that
use i.d. inoculations (along with fully virulent strains) should be given
priority when studying the pathogenesis of Y. pestis.
ACKNOWLEDGMENTS
This work was supported by grants R21AI105271 and U54AI057157
(Southeast Regional Center for Biodefense and Emerging Infectious Dis-
eases, project 006) from NIH to V.L.M. and the Robert D. Watkins Fel-
lowship from the American Society for Microbiology to R.J.G. This re-
search was conducted while M. Chelsea Lane was a postdoctoral fellow at
the University of North Carolina, Chapel Hill.
We thank Kim Walker for valuable assistance in critically reviewing
the manuscript.
REFERENCES
1. Chong SZ, Evrard M, Ng LG. 2013. Lights, camera, and action: vertebrate
skin sets the stage for immune cell interaction with arthropod-vectored
pathogens. Front Immunol 4:286. http://dx.doi.org/10.3389/fimmu.2013
.00286.
2. Nestle FO, Di Meglio P, Qin J-Z, Nickoloff BJ. 2009. Skin immune
sentinels in health and disease. Nat Rev Immunol 9:679 – 691. http://dx
.doi.org/10.1038/nri2622.
3. Teunissen MBM, Haniffa M, Collin MP. 2012. Insight into the immu-
nobiology of human skin and functional specialization of skin dendritic
cell subsets to innovate intradermal vaccination design. Curr Top Micro-
biol Immunol 351:25–76. http://dx.doi.org/10.1007/82_2011_169.
4. Frischknecht F. 2007. The skin as interface in the transmission of arthro-
pod-borne pathogens. Cell Microbiol 9:1630 –1640. http://dx.doi.org/10
.1111/j.1462-5822.2007.00955.x.
5. Sebbane F, Jarrett CO, Gardner D, Long D, Hinnebusch BJ. 2006. Role
of the Yersinia pestis plasminogen activator in the incidence of distinct
septicemic and bubonic forms of flea-borne plague. Proc Natl Acad Sci
U S A 103:5526 –5530. http://dx.doi.org/10.1073/pnas.0509544103.
6. Choumet V, Attout T, Chartier L, Khun H, Sautereau J, Robbe-Vincent
A, Brey P, Huerre M, Bain O. 2012. Visualizing non infectious and
infectious Anopheles gambiae blood feedings in naive and saliva-
immunized mice. PLoS One 7:e50464. http://dx.doi.org/10.1371/journal
.pone.0050464.
7. Belkaid Y, Kamhawi S, Modi G, Valenzuela J, Noben-Trauth N, Row-
ton E, Ribeiro J, Sacks DL. 1998. Development of a natural model of
cutaneous leishmaniasis: powerful effects of vector saliva and saliva pre-
exposure on the long-term outcome of Leishmania major infection in the
mouse ear dermis. J Exp Med 188:1941–1953. http://dx.doi.org/10.1084
/jem.188.10.1941.
8. Bos KI, Schuenemann VJ, Golding GB, Burbano HA, Waglechner N,
Coombes BK, McPhee JB, DeWitte SN, Meyer M, Schmedes S, Wood
J, Earn DJD, Herring DA, Bauer P, Poinar HN, Krause J. 2011. A draft
genome of Yersinia pestis from victims of the Black Death. Nature 478:
506 –510. http://dx.doi.org/10.1038/nature10549.
9. Butler T. 2013. Plague gives surprises in the first decade of the 21st century
in the United States and worldwide. Am J Trop Med Hyg 89:788 –793.
http://dx.doi.org/10.4269/ajtmh.13-0191.
10. Wimsatt J, Biggins DE. 2009. A review of plague persistence with special
emphasis on fleas. J Vector Borne Dis 46:85–99.
11. Gonzalez RJ, Lane MC, Wagner NJ, Weening EH, Miller VL. 2015.
Dissemination of a highly virulent pathogen: tracking the early events that
define infection. PLoS Pathog 11:e1004587. http://dx.doi.org/10.1371
/journal.ppat.1004587.
12. Sebbane F, Gardner D, Long D, Gowen BB, Hinnebusch BJ. 2005. Kinetics
of disease progression and host response in a rat model of bubonic plague. Am
J Pathol 166:1427–1439. http://dx.doi.org/10.1016/S0002-9440(10)62360-7.
13. Demeure CE, Blanchet C, Fitting C, Fayolle C, Khun H, Szatanik M,
Milon G, Panthier J-J, Jaubert J, Montagutelli X, Huerre M, Cavaillon
J-M, Carniel E. 2012. Early systemic bacterial dissemination and a rapid
innate immune response characterize genetic resistance to plague of SEG
mice. J Infect Dis 205:134 –143. http://dx.doi.org/10.1093/infdis/jir696.
14. Lenz JD, Lawrenz MB, Cotter DG, Lane MC, Gonzalez RJ, Palacios M,
Miller VL. 2011. Expression during host infection and localization of
Yersinia pestis autotransporter proteins. J Bacteriol 193:5936 –5949. http:
//dx.doi.org/10.1128/JB.05877-11.
15. Abu Khweek A, Fetherston JD, Perry RD. 2010. Analysis of HmsH and
its role in plague biofilm formation. Microbiology 156:1424 –1438. http:
//dx.doi.org/10.1099/mic.0.036640-0.
16. Oyston PC, Dorrell N, Williams K, Li SR, Green M, Titball RW, Wren BW.
2000. The response regulator PhoP is important for survival under conditions
of macrophage-induced stress and virulence in Yersinia pestis. Infect Immun
68:3419 –3425. http://dx.doi.org/10.1128/IAI.68.6.3419-3425.2000.
17. Hinnebusch BJ. 2005. The evolution of flea-borne transmission in Yer-
sinia pestis. Curr Issues Mol Biol 7:197–212.
18. Parkhill J, Wren BW, Thomson NR, Titball RW, Holden MT, Prentice
MB, Sebaihia M, James KD, Churcher C, Mungall KL, Baker S, Basham D,
Bentley SD, Brooks K, Cerdeño-Tárraga AM, Chillingworth T, Cronin A,
Davies RM, Davis P, Dougan G, Feltwell T, Hamlin N, Holroyd S, Jagels
K, Karlyshev AV, Leather S, Moule S, Oyston PC, Quail M, Rutherford K,
Simmonds M, Skelton J, Stevens K, Whitehead S, Barrell BG. 2001.
Genome sequence of Yersinia pestis, the causative agent of plague. Nature
413:523–527. http://dx.doi.org/10.1038/35097083.
19. Doll JM, Zeitz PS, Ettestad P, Bucholtz AL, Davis T, Gage K. 1994.
Cat-transmitted fatal pneumonic plague in a person who traveled from
Colorado to Arizona. Am J Trop Med Hyg 51:109 –114.
20. Cathelyn JS, Crosby SD, Lathem WW, Goldman WE, Miller VL. 2006.
RovA, a global regulator of Yersinia pestis, specifically required for bu-
bonic plague. Proc Natl Acad Sci U S A 103:13514 –13519. http://dx.doi
.org/10.1073/pnas.0603456103.
21. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromo-
somal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad
Sci U S A 97:6640 – 6645. http://dx.doi.org/10.1073/pnas.120163297.
22. Walters MS, Lane MC, Vigil PD, Smith SN, Walk ST, Mobley HLT.
2012. Kinetics of uropathogenic Escherichia coli metapopulation move-
ment during urinary tract infection. mBio 3(1):e00303-11. http://dx.doi
.org/10.1128/mBio.00303-11.
23. Van den Broeck W, Derore A, Simoens P. 2006. Anatomy and nomen-
clature of murine lymph nodes: descriptive study and nomenclatory stan-
dardization in BALB/cAnNCrl mice. J Immunol Methods 312:12–19.
http://dx.doi.org/10.1016/j.jim.2006.01.022.
24. National Research Council. 2011. Guide for the care and use of laboratory
animals, 8th ed. National Academies Press, Washington, DC.
25. Guinet F, Carniel E. 2003. A technique of intradermal injection of Yer-
sinia to study Y. pestis physiopathology. Adv Exp Med Biol 529:73–78.
26. Bosio CF, Jarrett CO, Gardner D, Hinnebusch BJ. 2012. Kinetics of
innate immune response to Yersinia pestis after intradermal infection in
a mouse model. Infect Immun 80:4034 – 4045. http://dx.doi.org/10.1128
/IAI.00606-12.
27. Weening EH, Cathelyn JS, Kaufman G, Lawrenz MB, Price P, Goldman
WE, Miller VL. 2011. The dependence of the Yersinia pestis capsule on
pathogenesis is influenced by the mouse background. Infect Immun 79:
644 – 652. http://dx.doi.org/10.1128/IAI.00981-10.
28. O’Mahony S, Rose SL, Chilvers AJ, Ballinger JR, Solanki CK, Barber
RW, Mortimer PS, Purushotham AD, Peters AM. 2004. Finding an
optimal method for imaging lymphatic vessels of the upper limb. Eur J
Nucl Med Mol Imaging 31:555–563. http://dx.doi.org/10.1007/s00259
-003-1399-3.
29. Shayan R, Achen MG, Stacker SA. 2006. Lymphatic vessels in cancer
metastasis: bridging the gaps. Carcinogenesis 27:1729 –1738. http://dx.doi
.org/10.1093/carcin/bgl031.
30. Kersey TW, Van Eyk J, Lannin DR, Chua AN, Tafra L. 2001. Compar-
ison of intradermal and subcutaneous injections in lymphatic mapping. J
Surg Res 96:255–259. http://dx.doi.org/10.1006/jsre.2000.6075.
31. Combadiere B, Liard C. 2011. Transcutaneous and intradermal vaccina-
tion. Hum Vaccin 7:811– 827. http://dx.doi.org/10.4161/hv.7.8.16274.
32. Bonnotte B, Gough M, Phan V, Ahmed A, Chong H, Martin F, Vile RG.
2003. Intradermal injection, as opposed to subcutaneous injection, en-
hances immunogenicity and suppresses tumorigenicity of tumor cells.
Cancer Res 63:2145–2149.
33. Cubas R, Zhang S, Kwon S, Sevick-Muraca EM, Li M, Chen C, Yao Q.
2009. Virus-like particle (VLP) lymphatic trafficking and immune re-
sponse generation after immunization by different routes. J Immunother
32:118 –128. http://dx.doi.org/10.1097/CJI.0b013e31818f13c4.
34. Liard C, Munier S, Arias M, Joulin-Giet A, Bonduelle O, Duffy D,
Shattock RJ, Verrier B, Combadiere B. 2011. Targeting of HIV-p24
particle-based vaccine into differential skin layers induces distinct arms of
the immune responses. Vaccine 29:6379 – 6391. http://dx.doi.org/10.1016
/j.vaccine.2011.04.080.
Intradermal and Subcutaneous Models of Bubonic Plague
July 2015 Volume 83 Number 7 iai.asm.org 2861Infection and Immunity
